Literature DB >> 7926688

Activation of blood clotting factors by microbial proteinases.

H Kaminishi1, H Hamatake, T Cho, T Tamaki, N Suenaga, T Fujii, Y Hagihara, H Maeda.   

Abstract

There are very few reports on the involvement of bacterial proteinases on the blood clotting system using both human plasma and purified clotting factors. We studied whether microbial proteinases from the opportunistic pathogens Candida albicans, Pseudomonas aeruginosa and Serratia marcescens activate the blood clotting cascade by using normal human plasma, human plasmas deficient in clotting factor XII or X, and also by using purified clotting factors XII, X and prothrombin. All proteinases tested activated either clotting factor XII or prothrombin in vitro, thus resulting in generation of thrombin. Clotting factor X was converted to the active form (Xa) by both Candida and Pseudomonas proteinases, but not by Serratia proteinase. These results suggest that peripheral and systemic blood circulation may be impaired by activation of the blood clotting cascade by microbial infections, especially in septic patients, which would enhance disseminated intravascular coagulation and multi-organ failure.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7926688     DOI: 10.1111/j.1574-6968.1994.tb07121.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  11 in total

1.  Losac, the first hemolin that exhibits procogulant activity through selective factor X proteolytic activation.

Authors:  Miryam Paola Alvarez-Flores; Daniel Furlin; Oscar H P Ramos; Andrea Balan; Katsuhiro Konno; Ana Marisa Chudzinski-Tavassi
Journal:  J Biol Chem       Date:  2010-12-22       Impact factor: 5.157

Review 2.  Factor XII: what does it contribute to our understanding of the physiology and pathophysiology of hemostasis & thrombosis.

Authors:  Evi Stavrou; Alvin H Schmaier
Journal:  Thromb Res       Date:  2010-03       Impact factor: 3.944

3.  Vibrio vulnificus secretes a broad-specificity metalloprotease capable of interfering with blood homeostasis through prothrombin activation and fibrinolysis.

Authors:  Alan K Chang; Hyo Young Kim; Jung Eun Park; Pankaj Acharya; Il-Seon Park; Seong Myeong Yoon; Ho Jin You; Kyung-Soo Hahm; Jong Kun Park; Jung Sup Lee
Journal:  J Bacteriol       Date:  2005-10       Impact factor: 3.490

Review 4.  Fungal proteases and their pathophysiological effects.

Authors:  Iwona Yike
Journal:  Mycopathologia       Date:  2011-01-23       Impact factor: 2.574

Review 5.  Serologic response to cell wall mannoproteins and proteins of Candida albicans.

Authors:  J P Martínez; M L Gil; J L López-Ribot; W L Chaffin
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

6.  Disruption of each of the secreted aspartyl proteinase genes SAP1, SAP2, and SAP3 of Candida albicans attenuates virulence.

Authors:  B Hube; D Sanglard; F C Odds; D Hess; M Monod; W Schäfer; A J Brown; N A Gow
Journal:  Infect Immun       Date:  1997-09       Impact factor: 3.441

Review 7.  The many faces of the contact pathway and their role in thrombosis.

Authors:  Rebecca S Woodruff; Bruce Sullenger; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2011-07       Impact factor: 2.300

8.  Degradation of humoral host defense by Candida albicans proteinase.

Authors:  H Kaminishi; H Miyaguchi; T Tamaki; N Suenaga; M Hisamatsu; I Mihashi; H Matsumoto; H Maeda; Y Hagihara
Journal:  Infect Immun       Date:  1995-03       Impact factor: 3.441

9.  Effective antiprotease-antibiotic treatment of experimental anthrax.

Authors:  Serguei G Popov; Taissia G Popova; Svetlana Hopkins; Raymond S Weinstein; Rebecca MacAfee; Karl J Fryxell; Vikas Chandhoke; Charles Bailey; Ken Alibek
Journal:  BMC Infect Dis       Date:  2005-04-08       Impact factor: 3.090

10.  Pseudomonas aeruginosa elastase cleaves a C-terminal peptide from human thrombin that inhibits host inflammatory responses.

Authors:  Mariena J A van der Plas; Ravi K V Bhongir; Sven Kjellström; Helena Siller; Gopinath Kasetty; Matthias Mörgelin; Artur Schmidtchen
Journal:  Nat Commun       Date:  2016-05-16       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.